Understanding the Role of the GRPEL2-AS1 Gene in Diseases (G106144529)

Target Name: GRPEL2-AS1

NCBI ID: G106144529

GRPEL2-AS1

Other Name(s): GRPEL2 antisense RNA 1

Understanding the Role of the GRPEL2-AS1 Gene in Diseases

Gene-related RNA expression (GRPEL2) is a highly conserved gene that has been implicated in various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. The protein encoded by the GRPEL2 gene, known as GRPEL2-AS1, has been shown to play a critical role in the development and progression of these diseases. As a result, targeting the GRPEL2-AS1 gene has become an attractive research focus in recent years.

In this article, we will explore the GRPEL2-AS1 gene and its potential as a drug target or biomarker. We will discuss the structure and function of the GRPEL2 gene, and the implications of its knockout or activation on various cellular processes. We will also examine the current research on GRPEL2-AS1 as a drug target, including its potential clinical trials and potential interactions with other drugs.

Structure and Function of the GRPEL2 Gene

The GRPEL2 gene is located on chromosome 6p21.1 and encodes a protein with 215 amino acid residues. The protein has a molecular weight of 23.9 kDa and a pre-mRNA melting constant of 59.2 kcal/mol. The protein is composed of a unique N -terminal transmembrane domain, a unique C-terminal transmembrane domain, and a unique N-terminal cytoplasmic domain.

The N-terminal transmembrane domain is made up of 11 amino acids and is responsible for the formation of the protein's Membrane-bound portion. The C-terminal transmembrane domain is made up of 12 amino acids and also plays a role in the formation of the protein's Membrane-bound portion. The N-terminal cytoplasmic domain is made up of 4 amino acids and is responsible for the formation of the protein's cytoplasmic portion.

The GRPEL2 gene has several unique features that are relevant to its function in cellular processes. One of the most significant is its ability to form a stable complex with RNA-protein hybrids. This interaction between the protein and RNA-protein hybrids is critical for the regulation of various cellular processes, including cell growth, apoptosis, and transcriptional regulation.

Another unique feature of the GRPEL2 gene is its ability to form a stable complex with DNA-protein hybrids. This interaction between the protein and DNA-protein hybrids is critical for the regulation of gene expression and DNA replication.

Implications of GRPEL2-AS1 Knockout or Activation on Various Cellular Processes

The GRPEL2 gene has been shown to play a critical role in the development and progression of various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. As a result, targeting the GRPEL2-AS1 gene has become an attractive research focus in recent years.

Studies have shown that GRPEL2-AS1 is involved in the regulation of various cellular processes, including cell growth, apoptosis, and transcriptional regulation. For example, GRPEL2-AS1 has been shown to play a role in the regulation of cell cycle progression, and its knockout has been shown to lead to the accumulation of apoptotic cells in the cell cycle.

In addition, GRPEL2-AS1 has also been shown to play a role in the regulation of apoptosis. Studies have shown that GRPEL2-AS1 can induce apoptosis in various cell types, including cancer cells, and that its inhibition can protect these cells from apoptosis.

GRPEL2-AS1 has also been shown to play a role in the regulation of transcriptional

Protein Name: GRPEL2 Antisense RNA 1

The "GRPEL2-AS1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about GRPEL2-AS1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets